Literature DB >> 21691937

Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis.

Amal El-Shehaby1, Hanan Darweesh, Mohamed El-Khatib, Mohamed Momtaz, Samar Marzouk, Nashwa El-Shaarawy, Yasser Emad.   

Abstract

OBJECTIVE: This case-controlled study was designed to correlate urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and interleukin-8 (IL-8) levels, with renal involvement in a cohort of systemic lupus erythematosus (SLE) patients to examine their diagnostic performance. PATIENTS AND METHODS: In 73 SLE patients, and in 23 healthy volunteers, urinary levels of TWEAK, OPG, MCP-1, and IL-8 levels were measured. Disease activity was assessed by total SLE disease activity index, and renal activity by renal activity index (rSLEDAI), and both were correlated with urinary biomarkers. Sensitivity, specificity, and predictive values of individual biomarkers to predict lupus nephritis were also calculated.
RESULTS: Significantly higher levels of urinary biomarkers were observed in SLE patients with lupus nephritis (LN) compared with those without LN (TWEAK, p < 0.001; MCP-1, p < 0.001; OPG, p < 0.001; IL-8, p < 0.032). Other significantly higher levels were observed in SLE patients with LN compared with control subjects (TWEAK, MCP-1, OPG, and IL-8 p < 0.001). Positive correlations were observed between rSLEDAI and TWEAK (r = 0.612 and p < 0.001), MCP-1 (r = 0.635 and p < 0.001), and OPG (r = 0.505 and p < 0.001).
CONCLUSIONS: Urinary levels of TWEAK, OPG, and MCP-1 positively correlate with renal involvement as assessed by rSLEDAI with reasonable sensitivity, specificity, and predictive values to detect lupus nephritis while IL-8 was not significantly associated with global or rSLEDAI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691937     DOI: 10.1007/s10875-011-9555-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

Review 1.  Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.

Authors:  Gabor G Illei; Edward Tackey; Larissa Lapteva; Peter E Lipsky
Journal:  Arthritis Rheum       Date:  2004-07

2.  Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare.

Authors:  S Tian; J Li; L Wang; T Liu; H Liu; G Cheng; D Liu; Y Deng; R Gou; Y Wan; J Jia; C Chen
Journal:  Inflamm Res       Date:  2007-07       Impact factor: 4.575

3.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

Review 4.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Authors:  Stephan Segerer; Peter J Nelson; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

5.  Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Authors:  Brad H Rovin; Huijuan Song; Dan J Birmingham; Lee A Hebert; Chack Yung Yu; Haikady N Nagaraja
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

6.  Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis.

Authors:  C Y Tsai; T H Wu; C L Yu; J Y Lu; Y Y Tsai
Journal:  Nephron       Date:  2000-07       Impact factor: 2.847

Review 7.  The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.

Authors:  Sean Campbell; Jennifer Michaelson; Linda Burkly; Chaim Putterman
Journal:  Front Biosci       Date:  2004-09-01

8.  TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.

Authors:  Alberto Molano; Payal Lakhani; Adi Aran; Linda C Burkly; Jennifer S Michaelson; Chaim Putterman
Journal:  Immunol Lett       Date:  2009-06-30       Impact factor: 3.685

9.  Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.

Authors:  Adnan N Kiani; Kristen Johnson; Catherine Chen; Edward Diehl; Huaizhong Hu; Ganesh Vasudevan; Sukhminder Singh; Laurence S Magder; Stuart J Knechtle; Michelle Petri
Journal:  J Rheumatol       Date:  2009-07-31       Impact factor: 4.666

10.  Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.

Authors:  M Noris; S Bernasconi; F Casiraghi; S Sozzani; E Gotti; G Remuzzi; A Mantovani
Journal:  Lab Invest       Date:  1995-12       Impact factor: 5.662

View more
  30 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

Review 2.  The TWEAK-Fn14 system as a potential drug target.

Authors:  Harald Wajant
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.

Authors:  Valentina Živković; Tatjana Cvetković; Branka Mitić; Bojana Stamenković; Sonja Stojanović; Biljana Radovanović-Dinić; Vladimir Jurišić
Journal:  Rheumatol Int       Date:  2017-11-27       Impact factor: 2.631

Review 4.  Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

5.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Authors:  Yumin Xia; Leal C Herlitz; Simona Gindea; Jing Wen; Rahul D Pawar; Alexander Misharin; Harris Perlman; Lan Wu; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 6.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 7.  Role of the TWEAK/Fn14 pathway in autoimmune diseases.

Authors:  Wang-Dong Xu; Yi Zhao; Yi Liu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

8.  Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.

Authors:  M N Salem; H A Taha; M Abd El-Fattah El-Feqi; N N Eesa; R A Mohamed
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

Review 9.  The pathogenesis, diagnosis and treatment of lupus nephritis.

Authors:  Noa Schwartz; Beatrice Goilav; Chaim Putterman
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 10.  TWEAK and the progression of renal disease: clinical translation.

Authors:  Ana B Sanz; M Concepcion Izquierdo; Maria Dolores Sanchez-Niño; Alvaro C Ucero; Jesus Egido; Marta Ruiz-Ortega; Adrián Mario Ramos; Chaim Putterman; Alberto Ortiz
Journal:  Nephrol Dial Transplant       Date:  2014-02       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.